Register entry

Guanghzou AiXin Biotech Co Ltd

Data as of · How to read this entry

Registered sites
1
Active NDC listings
2
Labeller names
2
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Labelling1Finished drug manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Guanghzou AiXin Biotech Co., LtdRegistrant: Guanghzou AiXin Biotech Co LtdRoom 306, Building 4, Sanfeng Creative Park, No.26 Changban Industrial Street, Jiahe Street, Baiyun District, Guangzhou, Guangdong 510000, China (CHN)Labelling, Finished drug manufacture3033036575712083870
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human otc drug. By marketing category: UNAPPROVED HOMEOPATHIC 2.

Dosage formNDCs
cream, augmented1
liquid1
RouteNDCs
cutaneous2
Labeller name on the listingNDCs
guanghzou aixin biotech co ltd1
guanghzou aixin biotech co., ltd1
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
BODY / FACE SUNSCREEN SUNBODY / FACE SUNSCREEN SUNcream, augmented, cutaneous85897-374UNAPPROVED HOMEOPATHIC
TINTED SUNSCREEN FOUNDATIONTINTED SUNSCREEN FOUNDATIONliquid, cutaneous85897-876UNAPPROVED HOMEOPATHIC
Neighbours

Registered in the same town

12
Compare

Comparable companies in China

Enquiry

Common questions

Is Guanghzou AiXin Biotech Co Ltd FDA approved?
Guanghzou AiXin Biotech Co Ltd holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Guanghzou AiXin Biotech Co Ltd's drugs manufactured?
The FDA register lists Guangzhou. Registered operations: labelling, finished drug manufacture.
What drugs does Guanghzou AiXin Biotech Co Ltd make?
2 products are listed under Guanghzou AiXin Biotech Co Ltd in the openFDA NDC Directory, most often as cream, augmented; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.